Diabetic ketoacidosis and severe dyslipidemia in an adult psychotic man with olanzapine treatment.
Kyriazis
Ioannis A
IA
Korovesis
Konstantinos
K
Bashir
Sidahmed
S
Liakouras
Andreas
A
Partheniou
Christos
C
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines / Q000009:adverse effects; D016883:Diabetic Ketoacidosis / Q000178:diet therapy / Q000188:drug therapy / Q000209:etiology*; D003927:Diet, Diabetic; D050171:Dyslipidemias / Q000178:diet therapy / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D000077152:Olanzapine
D014150:Antipsychotic Agents; D007004:Hypoglycemic Agents; D007328:Insulin; D001569:Benzodiazepines; D000077152:Olanzapine